Cancer cells shift toward the preferential expression of the specific isoform of PKM2, especially its dimeric form, and serve as a pivotal metabolic enzyme that promotes the activation of oncogenic pathways in tumors (Icard et al., 2022). This evidence concerns the gene PKM and cancer.